Drugs / antilymphocyte serum
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00000597 | Mar 1982 → Dec 1988 | aplastic anemia, pancytopenia | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00200551 Background | Jan 2001 → Apr 2010 | — | Nantes University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | antilymphocyte serum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000597 ↗ |
| Modality | Protein / enzyme biologic | “This serum, produced by immunization of horses with human thymocytes” NCT00000597 ↗ |